Amplitude Surgical (Paris:AMPLI) (ISIN: FR0012789667, Ticker: AMPLI, PEA-PME eligible), a leading player on the global surgical technology market for lower-limb orthopedics, today announces the completion of a new 65 million euro bond issue. This new bond debt has enabled the Group to carry out the early repayment of 35 million euros of its previous debt while providing it with an additional 30 million euros, which will give the Group the necessary financial resources to pursue its international development.

Philippe Garcia, CFO of Amplitude Surgical, says: “This bond issuance represents a key milestone to strengthen our financial structure. With a more favorable interest rate and greater financial flexibility, this additional 30 million euros of funding will enable us to finance our expansion, notably in the United States, and to move into new territories.”

This new bond debt carries a 5% annual coupon and has a maturity of six years. The terms of the existing residual debt have been significantly improved, with a 100-bp reduction in the margin and a 2-year extension of the maturity date to September 2023.

About Amplitude Surgical

Founded in 1997 in Valence, France, Amplitude Surgical is a leading French player on the global surgical technology market for lower-limb orthopedics. Amplitude Surgical develops and markets high-end products for orthopedic surgery covering the main disorders affecting the hip, knee and extremities, and notably foot and ankle surgery. Amplitude Surgical develops, in close collaboration with surgeons, numerous high value-added innovations in order to best meet the needs of patients, surgeons and healthcare facilities. A leading player in France, Amplitude Surgical is developing abroad through its subsidiaries and a network of exclusive distributors and agents. Amplitude Surgical operates on the lower-limb market through the intermediary of its Novastep subsidiaries in France and the United States. Amplitude Surgical distributes its products in more than 30 countries. At June 30, 2016, Amplitude Surgical had a workforce of almost 300 employees and recorded sales of over 80 million euros.

MINNETONKA, Minn.–(BUSINESS WIRE)–UnitedHealthcare has launched a new value-based care payment for knee, hip and spine procedures that focuses on quality patient care and better outcomes. The initiative – the Spine and Joint Solution – is available to employers nationwide and works with health care facilities that perform a higher number of these surgeries and have demonstrated better outcomes and fewer complications.

The Spine and Joint Solution gives UnitedHealthcare employer-sponsored plan participants access to surgeons and facilities that qualify as UnitedHealthcare Centers of Excellence and accept bundled case rates for certain procedures, including knee and hip replacement, spinal fusion and spinal disc repair. The program currently includes more than 40 health care facilities in 25 markets across the country, with plans to expand to more than 40 markets during 2017.

The bundled payment method reimburses a care provider or hospital for a defined episode of care, such as knee or hip replacement, under a single fee or payment. This is a shift away from the common fee-for-service structure in which a care provider is paid for each treatment, appointment or test, generating multiple claims within a single, broader episode of care.

The Spine and Joint Solution is currently available nationwide to large and mid-sized companies with self-funded health plans, helping expand access to high-quality, cost-effective care and potentially saving employees out-of-pocket costs. Since the program’s introduction as a pilot in 2015, participating employers have recorded an average savings of $10,000 or more per operation when compared with median costs in the same metropolitan area. Through the initiative, eligible employees may save more than $1,000 in out-of-pocket costs per procedure when accessing a participating facility rather than another in-network medical facility.

Musculoskeletal procedures are becoming increasingly common due to an aging population and higher obesity rates. For instance, the number of knee replacement surgeries performed nationally is expected to increase by 500 percent by 2030, according to a recent studyfrom the Healthcare Cost and Utilization Project. Moreover, these surgical procedures are expensive (knee/hip replacements average $35,000 per operation), and costs vary widely among care providers.

“Knee, hip and spine surgeries are among of the fastest increasing categories of medical procedures, so this program provides a new way to help improve the quality of care, produce better outcomes for patients and better manage costs for employers,” said Sam Ho, M.D., chief medical officer of UnitedHealthcare. “Our partnership with participating health care providers and facilities is an important step toward achieving better health outcomes while reducing the overall cost of care.”

UnitedHealthcare Value-Based Care Portfolio Continues to Grow
Value-based care models have made tremendous gains in adoption across America’s health care system over the last few years. UnitedHealthcare’s care provider reimbursements that are tied to a variety of value-based care arrangements have nearly tripled in the last three years to nearly $50 billion annually, and are expected to reach $65 billion by the end of 2018. To date, more than 14 million people, or nearly one in every three people enrolled in UnitedHealthcare benefit plans, currently access care from providers in value-based care relationships.

The Spine and Joint Solution currently partners with health care facilities that have been independently evaluated for providing quality patient care and better outcomes. Participating facilities are located in major markets nationwide, including Boston, Chicago, Dallas and Los Angeles.

“Providing the best outcomes and an exceptional patient experience in an affordable way are key to helping our patients live healthier lives,” said Tim Cappel, executive director of Population Health Management for Cincinnati’s The Christ Hospital, one of first facilities to participate in the program. “Employers seeking effective cost-containment strategies recognize the value of fixed and competitive prices. Through these and other innovative approaches, The Christ Hospital Health Network is transforming the way our patients receive care.”

For more information about the Spine and Joint Solution and Value-Based Care, visit www.uhc.com/valuebasedcare.

About UnitedHealthcare
UnitedHealthcare is dedicated to helping people nationwide live healthier lives by simplifying the health care experience, meeting consumer health and wellness needs, and sustaining trusted relationships with care providers. The company offers the full spectrum of health benefit programs for individuals, employers, military service members, retirees and their families, and Medicare and Medicaid beneficiaries, and contracts directly with 1 million physicians and care professionals, and 6,000 hospitals and other care facilities nationwide. UnitedHealthcare is one of the businesses of UnitedHealth Group (NYSE: UNH), a diversified Fortune 50 health and well-being company. For more information, visit UnitedHealthcare at www.uhc.com or follow @myUHC on Twitter.

Click here to subscribe to Mobile Alerts for UnitedHealth Group.

RENO, Nev.–(BUSINESS WIRE)–The Orthopaedic Implant Company (OIC), a medical device company that specializes in high-value orthopaedic implants, announced today the publication of an independent study examining the clinical and economic impact high-value orthopaedic implants have on the market.

“The Clinical and Economic Impact of Generic Locking Plate Utilization at a Level II Trauma Center,” published in the Journal of Orthopaedic Trauma, examines the performance of a hospital’s cost containment program utilizing high-value orthopaedic trauma implants provided by The Orthopaedic Implant Company (OIC). Plates available for the study were pre-contoured, anatomic and variable-angle locking plates indicated for small fragment fractures of the clavicle, radius, humerus, tibia and fibula.

The study compares the cost and outcomes of 828 patients, half of whom received generic implants while the other half received conventional implants. Conclusions found clinical outcomes to be comparable and savings averaged $1,197 per case, or $458,080 collectively.

“We are pleased to see the positive impact our products have had for patients , not just clinically but financially as well,” said Itai Nemovicher, President and CEO of OIC. “Similar to the results seen with generic pharmaceuticals, this study validates the effectiveness that generic implants have in today’s value-driven healthcare environment.”

About Orthopaedic Implant Company: OIC entered the medical device market in 2010 with an innovative approach to delivering the highest quality implants at the lowest possible prices. OIC implants cost 50 to 60 percent less than the average market price of premium implants, saving health care systems millions of dollars a year. OIC’s high-quality, low-cost implants and products can be used for a variety of procedures, including treatment of orthopaedic trauma and spinal injuries.